There is no single “normal” benzodiazepine level in urine. Urine drug tests for benzodiazepines are designed as positive-or-negative screens, not measurements of how much is in your system. A standard screening test uses a cutoff of 200 or 300 ng/mL, depending on the lab. Anything above that threshold is reported as positive, and anything below it is reported as negative. The actual concentration in your urine depends on which benzodiazepine you take, your dose, when you last took it, and how hydrated you are.
How Urine Tests Actually Work
Most urine drug tests use an immunoassay, a quick screening method that detects whether benzodiazepine-like compounds are present above a set cutoff. The antibodies in most commercial test kits are designed to react to specific breakdown products, particularly oxazepam and nordiazepam. This means the test is better at detecting some benzodiazepines than others.
If a screening test comes back positive, a confirmation test using mass spectrometry (GC/MS or LC-MS/MS) can identify exactly which benzodiazepine is present and at what concentration. Mass spectrometry is far more accurate. In comparative studies, immunoassay screens had a specificity of about 96% but sensitivity as low as 36% to 75%, depending on the brand. That means initial screens catch most true negatives but can miss real positives, especially for certain drugs at low concentrations. Mass spectrometry remains the most reliable method for detecting benzodiazepines in urine.
Why Specific Concentrations Vary So Much
Your body doesn’t excrete benzodiazepines in their original form. The liver first breaks them down through a series of chemical reactions, then attaches a sugar molecule (glucuronic acid) to make them water-soluble enough for the kidneys to filter out. Only a very small or negligible amount of the parent drug appears unchanged in urine. What the test actually detects are these processed byproducts.
Because of this, the concentration in any given urine sample is shaped by several factors: your lean body weight, the pH of your urine, your prescribed dose, your kidney function (reflected by creatinine levels in the sample), and how much water you’ve been drinking. A very dilute urine sample can push levels below the test’s cutoff even when you’re taking the medication as prescribed, while a concentrated sample can show higher-than-expected levels. This is why labs often measure creatinine alongside the drug screen, to check whether the sample is too dilute or too concentrated to be reliable.
Detection Windows by Drug
Different benzodiazepines stay detectable for different lengths of time. Here are approximate detection windows in urine:
- Alprazolam (Xanax): 1 to 4 days
- Clonazepam (Klonopin): 1 to 4 days
- Temazepam (Restoril): 1 to 4 days
- Diazepam (Valium): 1 to 7 days
- Lorazepam (Ativan): 1 to 7 days
- Oxazepam: 1 to 7 days
- Chlordiazepoxide (Librium): 1 to 10 days
These ranges are approximate. Duration of use, body composition, dosage, and individual metabolic differences all shift the window. Someone who has taken diazepam daily for years will test positive longer than someone who took a single dose.
Some Benzodiazepines Are Harder to Detect
Not all benzodiazepines trigger a positive result equally. Because most immunoassay kits target oxazepam and nordiazepam, drugs that break down into those compounds (like diazepam) are reliably caught. Alprazolam also cross-reacts well with standard screening antibodies through its main metabolite.
Lorazepam is a notable exception. It breaks down into lorazepam glucuronide, which many immunoassay kits do not detect well. Studies have specifically flagged lorazepam and the related drug lormetazepam as prone to false negatives on screening tests. If you take lorazepam as prescribed and test negative on a standard screen, this doesn’t necessarily mean the drug isn’t in your system. A confirmation test using mass spectrometry can pick up lorazepam at concentrations that immunoassays miss entirely.
Therapeutic Levels Are Measured in Blood, Not Urine
If you’re looking for a “normal” level to confirm you’re within a therapeutic range, those references exist only for blood (serum or plasma), not urine. Established therapeutic blood ranges include:
- Alprazolam: 10 to 50 ng/mL
- Clonazepam: 15 to 60 ng/mL
- Lorazepam: 50 to 240 ng/mL
- Diazepam: 100 to 1,000 ng/mL
Urine concentrations don’t translate directly to blood levels because urine reflects accumulated metabolites over hours, while blood reflects what’s circulating right now. A urine test tells you whether someone has had the drug in their system recently. A blood test tells you how much is active in their body at that moment. Clinicians use blood levels when they need to assess whether a dose is therapeutic or potentially toxic.
False Positives on Screening Tests
Two commonly used medications can trigger a false-positive benzodiazepine result on immunoassay screens: oxaprozin (an anti-inflammatory sold as Daypro) and sertraline (the antidepressant Zoloft). These drugs are chemically different from benzodiazepines but can cross-react with the antibodies in the test kit.
A false positive on an initial screen is resolved through confirmation testing with mass spectrometry, which can distinguish the actual compounds present. If you’re taking either of these medications and are asked to do a urine drug test, mentioning them beforehand can help avoid unnecessary concern while confirmation results are pending.
What Your Results Actually Mean
A positive result on a urine benzodiazepine test means the sample contained metabolites above the lab’s cutoff threshold. It confirms recent exposure but does not tell you the dose taken, when the last dose was, or whether the level is “normal” for your prescription. A negative result means the metabolite concentration fell below the cutoff, which could mean no recent use, a very dilute sample, or a drug the test isn’t sensitive to (like lorazepam on a standard screen).
If you’re being monitored for medication compliance, such as in a pain management program, your provider may order quantitative testing that reports actual concentrations alongside your prescribed dose, body weight, and urine creatinine. This gives a more complete picture than a simple positive or negative. The concentration is then compared against expected ranges for your specific drug and dose rather than a universal “normal” number.